Novel Mechanisms for the Antifibrotic Action of Nintedanib-Reference-Cited by-同舟云学术

Novel Mechanisms for the Antifibrotic Action of Nintedanib

Published:2016-01 Issue:1 Volume:54 Page:51-59
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Rangarajan Sunad^ORCID,Kurundkar Ashish^ORCID,Kurundkar Deepali^ORCID,Bernard Karen,Sanders Yan Y.,Ding Qiang,Antony Veena B.,Zhang Jianhua,Zmijewski Jaroslaw,Thannickal Victor J.

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Reference38 articles.

1. Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

2. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

3. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis

4. BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy

5. Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidyl arginine deiminase-4 inhibitor ameliorates pulmonary fibrosis through positive regulation of developmental endothelial locus-1;International Immunopharmacology;2024-10

2. The tyrosine kinase inhibitor Nintedanib induces lysosomal dysfunctionality: role of protonation-dependent crystallization processes;Chemico-Biological Interactions;2024-09

3. The Role of Transforming Growth Factor-β (TGF-β) in Asthma and Chronic Obstructive Pulmonary Disease (COPD);Cells;2024-07-29

4. The role of quercetin in ameliorating bleomycin-induced pulmonary fibrosis: insights into autophagy and the SIRT1/AMPK signaling pathway;Molecular Biology Reports;2024-07-13

5. 5,7,3′,4′-Tetramethoxyflavone suppresses TGF-β1-induced activation of murine fibroblasts in vitro and ameliorates bleomycin-induced pulmonary fibrosis in mice;Immunopharmacology and Immunotoxicology;2024-07